Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Kewen Shi Clear advanced filters
  • The intrinsic robustness to perturbations makes antiferromagnets ideal building blocks for spintronic devices, however, it also manipulation and detection of antiferromagnetic ordering difficult. Here, Xu et al demonstrate an anisotropic tunnelling magnetoresistance in an all-antiferromagnetic tunnel junction.

    • Shijie Xu
    • Zhizhong Zhang
    • Weisheng Zhao
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-9
  • SARS-CoV-2 uses ACE2 as the entry receptor. Here, the authors show that an ACE2-Ig fusion protein inhibits entry of virus pseudotyped with the SARS-CoV-2 spike protein, show differential binding kinetics of SARS-CoV and SARSCoV-2 spike proteins to ACE2, and determine pharmakocinetic parameters of ACE2-Ig in mice.

    • Changhai Lei
    • Kewen Qian
    • Shi Hu
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-5
  • Lyophilized lymph nodes are a natural scaffold to deliver chimeric antigen receptor (CAR) T cells to tumour resection sites, where they serve as a natural T cell-supporting niche and enhance CAR T cell efficacy in reducing recurrence in preclinical tumour resection models.

    • Kewen Lei
    • Darrell J. Irvine
    News & Views
    Nature Materials
    Volume: 23, P: 735-736
  • Antiferromagnetism of the IrMn layer in Pt/IrMn/CoFeB/MgO/CoFeB three-terminal magnetic tunnel junctions can be electrically detected using tunnelling magnetoresistance and controlled by a spin–orbit torque generated by a 0.8 ns current pulse applied across the heavy-metal platinum layer.

    • Ao Du
    • Daoqian Zhu
    • Weisheng Zhao
    Research
    Nature Electronics
    Volume: 6, P: 425-433
  • Genetically engineered T cells expressing a chimeric antigen receptor (CAR-T cells) are a promising new treatment for cancer, but are associated with unique toxicities. Here, the authors test CAR-T-cell-derived exosomes as a surrogate for CAR-T cells and show that they can elicit a potent antitumour immune response in preclinical models of breast cancer with reduced signs of cytokine release syndrome compared with CAR-T therapy.

    • Wenyan Fu
    • Changhai Lei
    • Shi Hu
    ResearchOpen Access
    Nature Communications
    Volume: 10, P: 1-12